Clinical Trials Browser

Phase 1/2 × Carcinoma, Renal Cell × ruxolitinib × Clear all

NCT07219576 2026-01-13

PRISM

Phase 1/2 Recruiting

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell